CS212264B2 - Method of making the 5-m-tolyloxyuracile - Google Patents
Method of making the 5-m-tolyloxyuracile Download PDFInfo
- Publication number
- CS212264B2 CS212264B2 CS774680A CS468077A CS212264B2 CS 212264 B2 CS212264 B2 CS 212264B2 CS 774680 A CS774680 A CS 774680A CS 468077 A CS468077 A CS 468077A CS 212264 B2 CS212264 B2 CS 212264B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- tolyloxyuracil
- acid
- compound
- sodium
- gastric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/706,123 US4080454A (en) | 1976-07-16 | 1976-07-16 | 5-M-Tolyloxyuracil, anti-ulcer agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS212264B2 true CS212264B2 (en) | 1982-03-26 |
Family
ID=24836300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS774680A CS212264B2 (en) | 1976-07-16 | 1977-07-13 | Method of making the 5-m-tolyloxyuracile |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4080454A (enExample) |
| JP (1) | JPS5337673A (enExample) |
| AR (1) | AR213652A1 (enExample) |
| AT (1) | AT351561B (enExample) |
| BE (1) | BE856710A (enExample) |
| CA (1) | CA1061788A (enExample) |
| CH (1) | CH622512A5 (enExample) |
| CS (1) | CS212264B2 (enExample) |
| DD (1) | DD131556A5 (enExample) |
| DE (1) | DE2731736A1 (enExample) |
| DK (1) | DK139029B (enExample) |
| EG (1) | EG12762A (enExample) |
| ES (1) | ES460686A1 (enExample) |
| FI (1) | FI772183A7 (enExample) |
| FR (1) | FR2358399A1 (enExample) |
| GB (1) | GB1542178A (enExample) |
| GR (1) | GR68686B (enExample) |
| HU (1) | HU177713B (enExample) |
| IL (1) | IL52409A (enExample) |
| LU (1) | LU77764A1 (enExample) |
| NL (1) | NL7707729A (enExample) |
| NO (1) | NO772489L (enExample) |
| PH (1) | PH13190A (enExample) |
| PL (1) | PL103783B1 (enExample) |
| PT (1) | PT66808B (enExample) |
| SE (1) | SE421125B (enExample) |
| SU (1) | SU673169A3 (enExample) |
| YU (1) | YU171677A (enExample) |
| ZA (1) | ZA773927B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55158095A (en) * | 1979-05-25 | 1980-12-09 | Zenkosha Tokei Kk | Controller for washing machine |
| KR101452518B1 (ko) * | 2005-08-22 | 2014-10-21 | 멜리어 파마슈티칼스 아이, 인코포레이티드 | Ｌｙｎ 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제 |
| EP2120581A4 (en) * | 2007-02-20 | 2011-03-16 | Melior Pharmaceuticals I Inc | METHODS OF IDENTIFYING LYN KINASE ACTIVATORS |
| EP2180894A4 (en) * | 2007-07-23 | 2012-08-29 | Melior Pharmaceuticals I Inc | METHOD OF ACTIVATING IRS-1 AND ACT |
| US8552184B2 (en) * | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
| WO2011150300A1 (en) * | 2010-05-28 | 2011-12-01 | Melior Pharmaceuticals I, Inc. | Prevention of pancreatic beta cell degeneration |
| EP3609500B1 (en) | 2017-04-10 | 2024-11-13 | Melior Pharmaceuticals I, Inc. | Treatment of adipocytes |
| CA3088178A1 (en) | 2018-02-21 | 2019-08-29 | Melior Pharmaceuticals I, Inc. | Treatment of liver diseases |
| WO2026125941A1 (en) | 2024-12-13 | 2026-06-18 | Biodexa Ltd. | Lyn kinase activators for use in treating fibrosis or diseases associated with fibrosis |
-
1976
- 1976-07-16 US US05/706,123 patent/US4080454A/en not_active Expired - Lifetime
-
1977
- 1977-06-27 CA CA281,423A patent/CA1061788A/en not_active Expired
- 1977-06-27 GR GR53819A patent/GR68686B/el unknown
- 1977-06-28 SE SE7707471A patent/SE421125B/xx unknown
- 1977-06-28 IL IL52409A patent/IL52409A/xx unknown
- 1977-06-29 ZA ZA00773927A patent/ZA773927B/xx unknown
- 1977-07-05 PH PH19953A patent/PH13190A/en unknown
- 1977-07-11 BE BE1008274A patent/BE856710A/xx unknown
- 1977-07-11 YU YU01716/77A patent/YU171677A/xx unknown
- 1977-07-11 FR FR7721285A patent/FR2358399A1/fr active Granted
- 1977-07-11 DE DE19772731736 patent/DE2731736A1/de not_active Withdrawn
- 1977-07-12 JP JP8349077A patent/JPS5337673A/ja active Granted
- 1977-07-12 NL NL7707729A patent/NL7707729A/xx not_active Application Discontinuation
- 1977-07-13 EG EG418/77A patent/EG12762A/xx active
- 1977-07-13 NO NO772489A patent/NO772489L/no unknown
- 1977-07-13 SU SU772502606A patent/SU673169A3/ru active
- 1977-07-13 DK DK318177AA patent/DK139029B/da unknown
- 1977-07-13 CH CH870277A patent/CH622512A5/fr not_active IP Right Cessation
- 1977-07-13 CS CS774680A patent/CS212264B2/cs unknown
- 1977-07-13 HU HU77PI583A patent/HU177713B/hu unknown
- 1977-07-13 FI FI772183A patent/FI772183A7/fi not_active Application Discontinuation
- 1977-07-13 ES ES460686A patent/ES460686A1/es not_active Expired
- 1977-07-14 AT AT509277A patent/AT351561B/de not_active IP Right Cessation
- 1977-07-14 DD DD7700200058A patent/DD131556A5/xx unknown
- 1977-07-14 GB GB7729667A patent/GB1542178A/en not_active Expired
- 1977-07-14 PT PT66808A patent/PT66808B/pt unknown
- 1977-07-14 LU LU77764A patent/LU77764A1/xx unknown
- 1977-07-14 PL PL1977199633A patent/PL103783B1/pl unknown
- 1977-07-14 AR AR268432A patent/AR213652A1/es active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0011609B2 (en) | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease | |
| JPH0788382B2 (ja) | 第三ヒドロキシアルキルキサンチン、それらの製造法及びそれを含有する治療剤 | |
| JPH0130834B2 (enExample) | ||
| PL146070B1 (en) | Method of obtaining 2-/n-substituted guanidin/4-/1,2,4-triazol-5-il/-thiazoles | |
| US20240316048A1 (en) | Prevention of Pancreatic Cell Degeneration | |
| EP0038674A1 (en) | Medicinal composition for treatment of allergic diseases | |
| CZ175496A3 (en) | 6-(2-imidazolinylamino)quinoxaline compounds usable as alpha-2 adrenoceptor agonists | |
| US4080454A (en) | 5-M-Tolyloxyuracil, anti-ulcer agent | |
| CA1054521A (en) | Biological materials | |
| EP0617959A1 (en) | Pharmaceutical for the treatment of skin disorders | |
| CS202506B2 (en) | Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids | |
| EP0551180B1 (en) | Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria | |
| CN112457291B (zh) | 苯并硫代吡喃酮类化合物的盐及其制备方法和用途 | |
| US4338319A (en) | Method for the treatment of chronic obstructive airway or cardiac diseases | |
| CA1302273C (en) | Pyrimidine derivatives for treatment of rheumatoid arthritis | |
| US6083958A (en) | Anti-HIV composition containing imidazole derivative | |
| AU609835B2 (en) | Antidiabetic agent | |
| KR0132568B1 (ko) | 이뇨 또는 항고혈압 조성물 | |
| US5475028A (en) | 2-aminoethanesulfonic acid zinc complex | |
| EP0082667A1 (en) | Pharmaceutical compositions | |
| US4107172A (en) | Uricosuric diuretic composition | |
| KR960014874B1 (ko) | 요산 배출용 조성물 | |
| JP2535633B2 (ja) | エチル ６―ブロモ―５―オキシ―４―ジメチルアミノメチル―１―メチル―２―フェニルチオメチルインド―ル―３―カルボキシレ―ト ハイドロクロライド モノハイドレ―ト，その調製方法、それを含む抗ウイルス性，インタ―フェロン―誘導及び免疫変調効果を持つ薬剤の調製 | |
| JP2003081843A (ja) | 有機ゲルマニウム化合物を有効成分とするｉｉ型糖尿病性腎症の発症予防又は治療剤。 | |
| JPS6041079B2 (ja) | オルト又はメタアミノ安息香酸誘導体 |